Latest: Watch here for details of new products and services.
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
- Companies
- Browse
Companies
Active Biotech AB is a Swedish biotech company focusing on the research and development of pharmaceuticals, primarily for the treatment of autoimmune / inflammatory diseases and cancer. More
Pharmaceuticals Division, Agrochemicals Division, Animal Health Division More
Sankyo Co. Ltd. is currently the second largest pharmaceutical company in Japan. It is famous as the founder of HMG-CoA reductase inhibitor anti-hyperlipidemia drugs. More
A drug development and discovery company that focuses on metabolic, neuromuscular and niche CNS disorders. More
Peptor based in Israel and Germany, is engaged in the discovery and development of novel therapies for the treatment of human autoimmune diseases and cancers. More
Isis Innovation is a wholly owned subsidiary of the University of Oxford, founded to exploit know-how arising out of research at one of the World's premier research institutions More
ReNeuron: developing neural stem cell technology for transplantation & in vitro uses. ReNeuron have licensed, and look to license further, technology which target neurodegenerative diseases More
Commercial exploitation company of The University of Manchester More
Scil Biomedicals business objective is to develop and market innovative, protein-based biopharmaceuticals and medical devices. More
A bio-pharmaceutical company seeking a partner to develop and exploit its sexual dysfunction product which would seem to be ideal for the U.S. nutraceutical market. More
Your selection
Browse By
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us